BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12296286)

  • 1. Sulphasalazine-induced systemic lupus erythematous in a patient with ankylosing spondylitis.
    Tsai WC; Chen CJ; Yen JH; Liu HW
    Clin Rheumatol; 2002 Aug; 21(4):339-40. PubMed ID: 12296286
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-induced systemic lupus erythematosus in ankylosing spondylitis associated with infliximab.
    Pérez-García C; Maymo J; Lisbona Pérez MP; Almirall Bernabé M; Carbonell Abelló J
    Rheumatology (Oxford); 2006 Jan; 45(1):114-6. PubMed ID: 16319096
    [No Abstract]   [Full Text] [Related]  

  • 3. Sulphasalazine-induced systemic lupus erythematosus in a patient with rheumatoid arthritis.
    Khattak FH; Morris IM; Mattingly PC
    Br J Rheumatol; 1996 Jan; 35(1):104. PubMed ID: 8624617
    [No Abstract]   [Full Text] [Related]  

  • 4. Sulphasalazine-induced aseptic meningitis with facial and nuchal edema in a patient with spondyloarthritis.
    Tay SH; Lateef A; Cheung PP
    Int J Rheum Dis; 2012 Aug; 15(4):e71-2. PubMed ID: 22898230
    [No Abstract]   [Full Text] [Related]  

  • 5. Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic disease.
    Borg AA
    Br J Rheumatol; 1995 Nov; 34(11):1097-8. PubMed ID: 8542218
    [No Abstract]   [Full Text] [Related]  

  • 6. Infliximab-induced lupus-like syndrome in a patient with ankylosing spondylitis.
    Bodur H; Eser F; Konca S; Arikan S
    Rheumatol Int; 2009 Feb; 29(4):451-4. PubMed ID: 18712523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced lupus-like syndrome in ankylosing spondylitis treated with infliximab.
    Mounach A; Ghazi M; Nouijai A; Ghozlani I; Achemlal L; Bezza A; El Maghraoui A
    Clin Exp Rheumatol; 2008; 26(6):1116-8. PubMed ID: 19210883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New and old therapeutic options in ankylosing spondylitis--is there an indication for sulfasalazine?].
    Braun J; Sieper J
    Z Rheumatol; 2002 Apr; 61(2):151-8. PubMed ID: 12056292
    [No Abstract]   [Full Text] [Related]  

  • 9. Late onset hypersensitivity to sulfasalazine in a patient with ankylosing spondylitis: comment on the article by Paul et al.
    Marino C; McDonald E
    Arthritis Care Res; 2000 Oct; 13(5):335; author reply 335. PubMed ID: 14635305
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of lupus-related side-effects in patients with early RA during sulphasalazine treatment-the role of IL-10 and HLA.
    Gunnarsson I; Nordmark B; Hassan Bakri A; Gröndal G; Larsson P; Forslid J; Klareskog L; Ringertz B
    Rheumatology (Oxford); 2000 Aug; 39(8):886-93. PubMed ID: 10952745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulphasalazine-induced systemic lupus erythematosus in a child.
    Vanheule BA; Carswell F
    Eur J Pediatr; 1983 Mar; 140(1):66-8. PubMed ID: 6135611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tinnitus and bilateral sensorineural hearing loss: ankylosing spondylitis or a side-effect of sulphasalazine treatment?
    Savastano M; Marioni G; Bernini G; Punzi L
    Acta Otolaryngol; 2005 Jun; 125(6):671-3. PubMed ID: 16076720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: a randomized, double-blind trial.
    Braun J; van der Horst-Bruinsma IE; Huang F; Burgos-Vargas R; Vlahos B; Koenig AS; Freundlich B
    Arthritis Rheum; 2011 Jun; 63(6):1543-51. PubMed ID: 21630245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulphasalazine-induced lupus in psoriatic arthritis.
    Veale DJ; Ho M; Morley KD
    Br J Rheumatol; 1995 Apr; 34(4):383-4. PubMed ID: 7788157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does sulphasalazine cause drug induced systemic lupus erythematosus? No effect evident in a prospective randomised trial of 200 rheumatoid patients treated with sulphasalazine or auranofin over five years.
    Gordon MM; Porter DR; Capell HA
    Ann Rheum Dis; 1999 May; 58(5):288-90. PubMed ID: 10225813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients.
    Dougados M; Boumier P; Amor B
    Br Med J (Clin Res Ed); 1986 Oct; 293(6552):911-4. PubMed ID: 2876744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulphasalazine-induced systemic lupus erythematosus in a patient with erosive arthritis.
    Walker EM; Carty JE
    Br J Rheumatol; 1994 Feb; 33(2):175-6. PubMed ID: 7909272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulphasalazine-induced systemic lupus erythematosus.
    Mongey AB; Hess EV
    Br J Rheumatol; 1994 Aug; 33(8):789-90. PubMed ID: 7914458
    [No Abstract]   [Full Text] [Related]  

  • 19. Sulphasalazine-induced cerebral lupus erythematosus.
    Rafferty P; Young AC; Haeney MR
    Postgrad Med J; 1982 Feb; 58(676):98-9. PubMed ID: 6124962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication toxicity among patients with ankylosing spondylitis.
    Ward MM; Kuzis S
    Arthritis Rheum; 2002 Jun; 47(3):234-41. PubMed ID: 12115151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.